drugset / Trial / NCT03905265
Dose-finding Study of Moxidectin for Treatment of Scabies
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The effective dose of moxidectin to treat human scabies is not known. This study aims to provide proof of concept that a single dose of moxidectin is effective in eliminating the scabies parasite in humans and to enable the determination of an optimal dose of moxidectin for treatment of scabies for further clinical studies.
Timeline
- Start
- 2020-01-13
- Primary completion
- 2022-02-28
- Completion
- 2022-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moxidectin | Other / unclassified | 2 mg | Oral |
| Subject | Moxidectin | Other / unclassified | 8 mg | Oral |
| Subject | Moxidectin | Other / unclassified | 20 mg | Oral |
| Subject | Moxidectin | Other / unclassified | 36 mg | Oral |